Donor heart preservation with hypoxic-conditioned medium-derived from bone marrow mesenchymal stem cells improves cardiac function in a heart transplantation model

[1] Burchill LJ(2012)Heart transplantation in adults with end-stage congenital heart disease Futur Cardiol 8 329-342

[2] Ross HJ(2012)The registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012 J Heart Lung Transplant 31 1073-1086

[3] Christie JD(2011)Heart transplantation Crit Care Nurs Clin North Am 23 471-479

[4] Edwards LB(2015)The mitochondria-targeted anti-oxidant MitoQ decreases ischemia-reperfusion injury in a murine syngeneic heart transplant model J Heart Lung Transplant 34 1471-1480

[5] Kucheryavaya AY(1998)Apoptosis and myocardial infarction Basic Res Cardiol 93 8-12

[6] Benden C(2012)Myocardial ischemia reperfusion injury: from basic science to clinical bedside Semin Cardiothorac Vasc Anesth 16 123-132

[7] Dipchand AI(2006)Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties Int J Cardiol 111 231-239

[8] Dobbels F(2002)Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects Ann Thorac Surg 73 1919-1925

[9] DiNella JV(2017)Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine Int J Mol Sci 18 1852-98

[10] Bowman J(2012)Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion Front Immunol 3 297-1084

[1] Burchill LJ(2012)Heart transplantation in adults with end-stage congenital heart disease Futur Cardiol 8 329-342

[2] Ross HJ(2012)The registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012 J Heart Lung Transplant 31 1073-1086

[3] Christie JD(2011)Heart transplantation Crit Care Nurs Clin North Am 23 471-479

[4] Edwards LB(2015)The mitochondria-targeted anti-oxidant MitoQ decreases ischemia-reperfusion injury in a murine syngeneic heart transplant model J Heart Lung Transplant 34 1471-1480

[5] Kucheryavaya AY(1998)Apoptosis and myocardial infarction Basic Res Cardiol 93 8-12

[6] Benden C(2012)Myocardial ischemia reperfusion injury: from basic science to clinical bedside Semin Cardiothorac Vasc Anesth 16 123-132

[7] Dipchand AI(2006)Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties Int J Cardiol 111 231-239

[8] Dobbels F(2002)Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects Ann Thorac Surg 73 1919-1925

[9] DiNella JV(2017)Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine Int J Mol Sci 18 1852-98

[10] Bowman J(2012)Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion Front Immunol 3 297-1084